29P First-line of camrelizumab, apatinib mesylate and chemotherapy for advanced high-grade neuroendocrine tumors (NETS): A single center, single arm, exploratory study

J. Xu, D. Zhu, Z. Liu, J. Cui, M. Liu, W. Hu, H. Fu, J. Zhao, X. Fan

ESMO Open（2024）

Cited 0|Views13

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined